oa SA Pharmaceutical Journal - Boniva® : the new quarterly intravenous osteoporosis treatment : drug info - new product focus

Volume 81, Issue 9
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



A Boniva® 3 mg/3 ml injection contains the bisphosphonate, ibandronate, and is indicated for the treatment of osteoporosis in postmenopausal women, in order to reduce the risk of vertebral fractures.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error